glutamic acid and Hepatocellular Carcinoma

glutamic acid has been researched along with Hepatocellular Carcinoma in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (25.00)18.2507
2000's4 (20.00)29.6817
2010's6 (30.00)24.3611
2020's5 (25.00)2.80

Authors

AuthorsStudies
Chen, L; Chen, P; Guo, H; Han, Z; He, Y; Hu, X; Li, Q; Liu, D; Liu, W; Luo, Y; Qi, L; Wu, Q; Zhang, X; Zhu, X1
Huang, Y; Li, M; Liu, Z; Lv, J; Ma, L; Tang, Z; Wang, K; Yang, C; Yu, H; Zhang, Y1
Annibale, L; Bhattacharyya, S; Colizzi, M; Collier, T; Das, D; Eranti, S; Kelbrick, M; Kempton, MJ; Lythgoe, D; McGuire, P; O'Neill, A; Onyejiaka, C; Sami, M; Williams, SCR; Worker, A1
Bakker, BM; Engqvist, M; Gerding, A; Haanstra, JR; Klingmüller, U; Nielsen, J; Nilsson, A; Teusink, B1
Fei, Z; Jing, Z; Lijuan, Y; Shuwen, H; Xi, Y; Yuefen, P1
Convertini, P; Dituri, F; Giannelli, G; Iacobazzi, V; Infantino, V; Mancarella, S; Palmieri, F; Santarsiero, A; Todisco, S1
Chen, M; Cheng, X; Fan, X; Gao, H; Ji, J; Lu, S; Song, J; Weng, Q; Xu, M; Yang, W; Zheng, H; Zheng, L1
Gilkes, DM; Hu, H; Luo, W; Semenza, GL; Takano, N; Xiang, L1
Kinukawa, H; Shirakawa, T; Yoshimura, T1
Chang, S; Jang, SJ; Kim, I; Lee, HY; Lee, SE; Park, S; Seol, HS; Singh, SR; Song, JS1
Bian, DJ; Chen, XY; Hu, DX; Situ, WJ; Sun, JL; Xiao, EH; Yang, LP; Yuan, SW1
Chen, M; Cheng, T; Ou, SH; Wu, T; Xia, NS; Xu, CY; Zhang, J; Zhang, T1
Allritz, C; Engele, J; Figiel, M; Lehmann, C1
Jeong, EG; Kim, MS; Lee, SH; Yoo, NJ1
Kato, Y; Kouno, M; Miyashita, M; Mizuno, H; Okabe, K; Sato, A; Suzuki, H; Suzuki, M; Tominaga, T1
Cousins, RB; Gaylor, JD; Grant, MH; Melkonian, AD1
Attardi, G; Greco, M; Papa, S; Villani, G1
Gotoh, K; Handa, H; Hirayama, A; Honjo, K; Uehara, S1
Moreno-Sánchez, R; Rodríguez-Enríquez, S; Torres-Márquez, ME1
Matsuno, T1

Other Studies

20 other study(ies) available for glutamic acid and Hepatocellular Carcinoma

ArticleYear
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma.
    Cell death & disease, 2022, 11-29, Volume: 13, Issue:11

    Topics: Autophagy; Carcinoma, Hepatocellular; Cystine; Ferroptosis; Glutamic Acid; Glutathione; Humans; Liver Neoplasms; RNA-Binding Proteins

2022
Formula optimization and in vivo study of poly(L-glutamic acid)-g-methoxy poly(ethylene glycol)/combretastatin A4/BLZ945 nanoparticles for cancer therapy.
    International journal of pharmaceutics, 2023, Apr-05, Volume: 636

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Glutamic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Polyethylene Glycols; Tissue Distribution

2023
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis.
    Translational psychiatry, 2020, 04-21, Volume: 10, Issue:1

    Topics: Cannabis; Carcinoma, Hepatocellular; Glutamic Acid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Psychotic Disorders

2020
Quantitative analysis of amino acid metabolism in liver cancer links glutamate excretion to nucleotide synthesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 05-12, Volume: 117, Issue:19

    Topics: Adenosine Triphosphate; Carcinoma, Hepatocellular; Cells, Cultured; Citric Acid Cycle; Cytosol; Energy Metabolism; Glutamic Acid; Glutamine; Hep G2 Cells; Humans; Liver Neoplasms; Mitochondria

2020
Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression.
    Human cell, 2021, Volume: 34, Issue:1

    Topics: Activating Transcription Factor 3; Alanine; Carcinoma, Hepatocellular; Disease Progression; Ferroptosis; Gene Expression Regulation, Neoplastic; Genetic Association Studies; Glutamic Acid; Heat-Shock Proteins; Humans; Liver Neoplasms; MAP Kinase Signaling System; Molecular Chaperones; NAD; Survival Rate

2021
Epigenetic upregulation and functional role of the mitochondrial aspartate/glutamate carrier isoform 1 in hepatocellular carcinoma.
    Biochimica et biophysica acta. Molecular basis of disease, 2019, Volume: 1865, Issue:1

    Topics: Amino Acid Transport Systems, Acidic; Antiporters; Aspartic Acid; Brain; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Glutamic Acid; Heart; Hep G2 Cells; Humans; Liver Neoplasms; Mitochondrial Membrane Transport Proteins; Muscle, Skeletal; Protein Isoforms; Up-Regulation

2019
Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via
    BioMed research international, 2019, Volume: 2019

    Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; Glucose; Glutamic Acid; Glutamine; Glutathione; Lipids; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolic Networks and Pathways; Rats; Rats, Sprague-Dawley

2019
Hypoxia-inducible factors enhance glutamate signaling in cancer cells.
    Oncotarget, 2014, Oct-15, Volume: 5, Issue:19

    Topics: Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 3; Gene Expression Regulation, Neoplastic; Glutamic Acid; HEK293 Cells; Heterografts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Liver Neoplasms; Male; Mice; Mice, SCID; Neoplasm Transplantation; Proto-Oncogene Proteins c-fyn; Receptors, AMPA; RNA Interference; RNA, Small Interfering; Signal Transduction; Von Hippel-Lindau Tumor Suppressor Protein

2014
Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II.
    Clinical biochemistry, 2015, Volume: 48, Issue:16-17

    Topics: Animals; Antibodies, Monoclonal; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line; Epitopes; Glutamic Acid; Humans; Hybridomas; Immunoassay; Immunologic Tests; Liver Neoplasms; Mice; Protein Precursors; Prothrombin; Thrombin

2015
Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
    Cancer letters, 2016, 11-28, Volume: 382, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Repositioning; Excitatory Amino Acid Antagonists; G2 Phase Cell Cycle Checkpoints; Glutamic Acid; Glutathione; Humans; Liver Neoplasms; Male; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Oxidative Stress; Reactive Oxygen Species; Riluzole; Signal Transduction; Tumor Burden; Tumor Cells, Cultured; Up-Regulation; Xenograft Model Antitumor Assays

2016
Magnetic resonance spectroscopy on hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Chinese journal of cancer, 2010, Volume: 29, Issue:2

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Choline; Female; Glucose; Glutamic Acid; Glutamine; Glycogen; Humans; Lipids; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged

2010
[Hydrophobicity of reactive site loop of SCCA1 affects its binding to HBV].
    Sheng wu gong cheng xue bao = Chinese journal of biotechnology, 2005, Volume: 21, Issue:1

    Topics: Antigens, Neoplasm; Binding Sites; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Glutamic Acid; Hepatitis B virus; Humans; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Protein Binding; Receptors, Virus; Serpins; Valine

2005
Gap junctional control of glial glutamate transporter expression.
    Molecular and cellular neurosciences, 2007, Volume: 35, Issue:1

    Topics: Animals; Anticonvulsants; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Connexin 43; Excitatory Amino Acid Transporter 2; Female; Gap Junctions; Glutamic Acid; Liver Neoplasms; Luciferases; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligodendroglia; Pregnancy; Propofol; Rats; Rats, Sprague-Dawley; RNA Interference; Stem Cells

2007
Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
    British journal of cancer, 2008, May-06, Volume: 98, Issue:9

    Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; DNA Mutational Analysis; Female; Glutamic Acid; Humans; Leukemia; Liver Neoplasms; Lung Neoplasms; Lysine; Male; Middle Aged; Mutation; Neoplasms; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins c-akt; Stomach Neoplasms

2008
Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases.
    Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1993, Volume: 1A

    Topics: Acute Disease; Biomarkers; Carcinoma, Hepatocellular; Chronic Disease; Fatty Liver, Alcoholic; gamma-Glutamyltransferase; Glutamates; Glutamic Acid; Glutamine; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Temperance

1993
Culture of a differentiated liver cell line, Hep G2, in serum with application to a bioartificial liver: effect of supplementation of serum with amino acids.
    Artificial organs, 1994, Volume: 18, Issue:8

    Topics: Amino Acids; Artificial Organs; Blood; Carcinoma, Hepatocellular; Cell Differentiation; Cell Division; Cell Survival; Culture Media; Cysteine; Glutamic Acid; Glutathione; Glycine; Humans; Liver; Liver Neoplasms; Tumor Cells, Cultured

1994
Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types.
    The Journal of biological chemistry, 1998, Nov-27, Volume: 273, Issue:48

    Topics: Adenosine Diphosphate; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line; Cell Membrane Permeability; Digitonin; Electron Transport Complex IV; Glutamic Acid; Humans; Kinetics; Liver Neoplasms; Lung Neoplasms; Malates; Mitochondria; Multiple Myeloma; Neuroblastoma; Osteosarcoma; Oxygen Consumption; Potassium Cyanide; Tetramethylphenylenediamine; Tumor Cells, Cultured

1998
Process of carboxylation of glutamic acid residues in the gla domain of human des-gamma-carboxyprothrombin.
    Clinica chimica acta; international journal of clinical chemistry, 1999, Volume: 289, Issue:1-2

    Topics: Adult; Aged; Amino Acid Motifs; Anticoagulants; Biomarkers; Biomarkers, Tumor; Carbon-Carbon Ligases; Carcinoma, Hepatocellular; Female; Glutamic Acid; Humans; Liver Neoplasms; Male; Peptide Fragments; Protein Precursors; Prothrombin; Vitamin K; Warfarin

1999
Substrate oxidation and ATP supply in AS-30D hepatoma cells.
    Archives of biochemistry and biophysics, 2000, Mar-01, Volume: 375, Issue:1

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adenosine Triphosphate; Animals; Carcinoma, Hepatocellular; Cell Division; Cell Respiration; Cytosol; Female; Glucose; Glutamic Acid; Glutamine; Glycogen; Glycolysis; Liver Neoplasms, Experimental; Mitochondria; Oxidation-Reduction; Oxidative Phosphorylation; Pyruvic Acid; Rats; Rats, Wistar; Substrate Specificity; Tumor Cells, Cultured

2000
Pathway of glutamate oxidation and its regulation in the HuH13 line of human hepatoma cells.
    Journal of cellular physiology, 1991, Volume: 148, Issue:2

    Topics: Alanine Transaminase; Aminooxyacetic Acid; Aspartate Aminotransferases; Bicarbonates; Carcinoma, Hepatocellular; Glutamate Dehydrogenase; Glutamates; Glutamic Acid; Glutamine; Humans; Liver Neoplasms; Mitochondria; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Succinates; Succinic Acid; Tumor Cells, Cultured

1991